Back to Screener

Healthcare

BioInvent International AB (publ)(BOVNF)

Live Price

Offline

$3.29

+0.00% today

Window Change

+0.00%

Window

Apr 16, 2026 โ†’ Jun 23, 2026

Market Cap
$1.45B
Revenue Growth
+405.6%
EPS Growth
+22.4%
Dividend Yield
0.0%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 47 bars ยท Apr 16, 2026 โ†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

BioInvent International AB (publ) (BOVNF) is a Healthcare stock with a market cap of $1.45B. The stock last traded around $3.29 and up 0.0% across the available one-year price window (Apr 16, 2026 โ†’ Jun 23, 2026). Baseline metrics include revenue growth of +405.6%, EPS growth of +22.4%, a dividend yield of 0.0%. What stands out right now is revenue +405.6%, EPS +22.4%, free cash flow +34.9% with operating margin -161.0% and ROIC -78.8%. Valuation sits in the middle of the pack at price/sales 6.7. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines BOVNF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

BOVNF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

BOVNF

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

BOVNF Max Drawdown

0.00%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for BOVNF and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedApr 29, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Apr 29, 26
โ€”
Est -0.20
โ€”
โ€”
Est 1565.2B
โ€”
Apr 29
โ€”
Feb 26, 26
-0.21
Est โ€”
โ€”
324.6B
Est โ€”
โ€”
Feb 26
โ€”
Aug 26, 25
0.06
Est โ€”
โ€”
20699.3B
Est โ€”
โ€”
Aug 26
โ€”
Apr 29, 25
-1.78
Est โ€”
โ€”
22060.0B
Est โ€”
โ€”
Apr 29
โ€”
Feb 27, 25
-1.78
Est โ€”
โ€”
21369.0B
Est โ€”
โ€”
Feb 27
โ€”
Oct 31, 24
-1.48
Est โ€”
โ€”
12764.0B
Est โ€”
โ€”
Oct 31
โ€”
Aug 29, 24
-2.09
Est โ€”
โ€”
4611.0B
Est โ€”
โ€”
Aug 29
โ€”
Apr 24, 24
-1.18
Est โ€”
โ€”
5942.0B
Est โ€”
โ€”
Apr 24
โ€”
Feb 22, 24
โœ—
-1.48
Est -0.11
-1250.7%
15319.0B
Est 888.3B
+1624.5%
Feb 22
โ€”
Sep 30, 23
โœ—
-1.08
Est -0.11
-855.3%
26797.0B
Est 729.6B
+3572.8%
Sep 30
โ€”
Jun 30, 23
โœ—
-1.34
Est -0.12
-1045.8%
13095.0B
Est 830.7B
+1476.4%
Jun 30
โ€”
Mar 31, 23
โœ—
-0.90
Est -0.12
-642.5%
16250.0B
Est 767.2B
+2018.1%
Mar 31
โ€”
Feb 22, 23
โœ“
-1.21
Est -1.25
+3.2%
20640.0B
Est 712.5B
+2796.8%
Feb 22
โ€”
Oct 27, 22
โœ“
-1.00
Est -1.17
+14.5%
17920.0B
Est 734.2B
+2340.8%
Oct 27
โ€”
Aug 24, 22
โœ“
2.86
Est -1.16
+346.6%
270907.0B
Est 3214.2B
+8328.4%
Aug 24
โ€”
Apr 27, 22
โœ“
-1.16
Est -1.67
+30.5%
16659.0B
Est 3504.6B
+375.4%
Apr 27
โ€”
Feb 23, 22
โœ“
-1.35
Est -1.37
+1.5%
4903.0B
Est 5954.0B
-17.6%
Feb 23
โ€”
Oct 27, 21
โœ“
-1.07
Est -1.71
+37.4%
2993.0B
Est โ€”
โ€”
Oct 27
โ€”
Aug 26, 21
โœ“
-0.98
Est -1.13
+13.3%
5288.0B
Est โ€”
โ€”
Aug 26
โ€”
Apr 28, 21
-1.94
Est โ€”
โ€”
6200.0B
Est โ€”
โ€”
Apr 28
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener